Literature DB >> 22688361

Non-tuberculous mycobacteria in cystic fibrosis.

Uta G Hill1, R Andres Floto, Charles S Haworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22688361      PMCID： PMC3372305          DOI： 10.1258/jrsm.2012.12s003

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  21 in total

1.  Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis.

Authors:  F-C Bange; E C Böttger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-07-12       Impact factor: 3.267

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 3.  Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria.

Authors:  R J Wallace; B A Brown; D E Griffith
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

4.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Authors:  Kenneth N Olivier; David J Weber; Richard J Wallace; Ali R Faiz; Ji-Hyun Lee; Yansheng Zhang; Barbara A Brown-Elliot; Allison Handler; Rebecca W Wilson; Michael S Schechter; Lloyd J Edwards; Subha Chakraborti; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

5.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

Authors:  Maurizio Renna; Catherine Schaffner; Karen Brown; Shaobin Shang; Marcela Henao Tamayo; Krisztina Hegyi; Neil J Grimsey; David Cusens; Sarah Coulter; Jason Cooper; Anne R Bowden; Sandra M Newton; Beate Kampmann; Jennifer Helm; Andrew Jones; Charles S Haworth; Randall J Basaraba; Mary Ann DeGroote; Diane J Ordway; David C Rubinsztein; R Andres Floto
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

Review 6.  Interferon-gamma and interleukin-12 pathway defects and human disease.

Authors:  S E Dorman; S M Holland
Journal:  Cytokine Growth Factor Rev       Date:  2000-12       Impact factor: 7.638

7.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Authors:  David E Griffith; Barbara A Brown-Elliott; Brett Langsjoen; Yansheng Zhang; Xi Pan; William Girard; Kenwyn Nelson; James Caccitolo; Julio Alvarez; Sara Shepherd; Rebecca Wilson; Edward A Graviss; Richard J Wallace
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

8.  Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.

Authors:  H Mussaffi; J Rivlin; I Shalit; M Ephros; H Blau
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

9.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.

Authors:  W Chalermskulrat; N Sood; I P Neuringer; T M Hecker; L Chang; M P Rivera; L J Paradowski; R M Aris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

10.  Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation--a case report.

Authors:  P Morales; J A Ros; M Blanes; D Pérez-Enguix; V Saiz; M Santos
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066
View more
  10 in total

Review 1.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

2.  Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design.

Authors:  Sherine E Thomas; William J McCarthy; Jamal El Bakali; Karen P Brown; So Yeon Kim; Michal Blaszczyk; Vítor Mendes; Chris Abell; R Andres Floto; Anthony G Coyne; Tom L Blundell
Journal:  Front Mol Biosci       Date:  2022-05-30

3.  Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.

Authors:  Laura M Filkins; Jyoti A Graber; Daniel G Olson; Emily L Dolben; Lee R Lynd; Sabin Bhuju; George A O'Toole
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

Review 4.  Nontuberculous mycobacterial pulmonary infections.

Authors:  Margaret M Johnson; John A Odell
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

5.  Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.

Authors:  Dilek Satana; Gonca Erkose-Genc; Zeynep Tamay; Meltem Uzun; Nermin Guler; Zayre Erturan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-13       Impact factor: 3.944

6.  Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients.

Authors:  Mathis Steindor; Vanesa Nkwouano; Ertan Mayatepek; Colin R Mackenzie; Dirk Schramm; Marc Jacobsen
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 7.  Nontuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Kate Skolnik; Gordon Kirkpatrick; Bradley S Quon
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-22

Review 8.  Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.

Authors:  Christiaan Dm Wijers; James F Chmiel; Benjamin M Gaston
Journal:  Chron Respir Dis       Date:  2017-03-06       Impact factor: 2.444

9.  Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium.

Authors:  Anaïs Scohy; Sophie Gohy; Vanessa Mathys; Guillaume Sapriel; Laëtitia Toussaint; Florian Bressant; Ali Zitouni; Marie-Noël Teylaert; Marie-Christine Vander Meeren; Alexandre Colmant; Anne Simon; John D Perry; Patrick Lebecque; Emmanuel André
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-08-01

10.  Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection.

Authors:  Mathis Steindor; Florian Stehling; Margarete Olivier; Jan Kehrmann; Margo Diricks; Florian P Maurer; Peter A Horn; Svenja Straßburg; Matthias Welsner; Sivagurunathan Sutharsan; Monika Lindemann
Journal:  Front Microbiol       Date:  2021-07-12       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.